IEIjeoma Julie Eche-Ugwu

Ijeoma Julie Eche-Ugwu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ijeoma Julie Eche-Ugwu has a total of 163 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    My anomaly

    by Ijeoma Julie Eche-Ugwu

  • Open Access

    Improving Intensive End-of-Life Care for Infants and Children: A Scoping Review of Intervention Elements

    by Elizabeth G. Broden Arciprete, Na Ouyang, Sarah E. Wawrzynski, Ijeoma J. Eche-Ugwu, Janene Batten, Deena K. Costa, Shelli L. Feder, Jennifer M. Snaman

    Background/objectives: High-quality pediatric critical care includes supporting children nearing the end-of-life (EOL) and their families. Cataloging existing interventions for children dying in the neonatal or pediatric intensive care unit (NICU, PICU) establishes critical areas for future research. In this scoping review, we evaluated characteristics of PICU EOL interventions. Methods: A librarian guided a search of OVID Medline, CINAHL, OVID PsycINFO, OVID Embase, Cochrane Central, and Web of Science, plus backwards and forwards reference searching. We included interprofessional interventions, defined as any systematic change (e.g., educational programs, symptom management, electronic medical record, etc.), for children dying from any cause. Studies were independently screened by two reviewers. Data were extracted by one team member and reviewed by a second. We extracted intervention elements, contextual factors, implementation barriers/facilitators, and generated frequencies from qualitative coding. Results: Of 11,643 screened articles, 44 met the inclusion criteria. Most were in neonatal ICUs (n = 28/44, 64%) and general PICUs (n = 10/44, 23%). Most interventions aimed to improve clinician knowledge (25/44, 57%), augment clinical structures and processes (n = 11/44, 25%), or enhance communication (n = 8/44, 18%). Common delivery methods included clinical practice changes (n = 25/44, 57%; e.g., protocols, order sets [n = 12]), and educational sessions (n = 20/44, 45%). Outcomes included clinician knowledge (n = 17/44, 39%), qualitative feedback (n = 18/44, 41%), feasibility/acceptability (n = 12/44, 27%), or treatment utilization (n = 11/44, 25%). Few examined families’ mental health (n = 3, 7%) or bereavement (n = 2, 5%). Few reported implementation facilitators or barriers. Conclusions: Most included studies targeted clinician outcomes through education. Designing, testing, and implementing interventions focused on family outcomes is a critical next step.


  • Open Access

    Improving Intensive End-of-Life Care for Infants and Children: A Scoping Review of Intervention Elements

    by Elizabeth Glyde Broden Arciprete, Na Ouyang, Sarah E. Wawrzynski, Ijeoma Julie Eche-Ugwu, Janene Batten, Deena K. Costa, Shelli L. Feder, Jennifer M. Snaman

    Background/objectives: High-quality pediatric critical care includes supporting children nearing the end-of-life (EOL) and their families. Cataloging existing interventions for children dying in the pediatric intensive care unit (PICU) establishes critical areas for future research. In this scoping review, we evaluated characteristics of PICU EOL in-terventions. Methods: A librarian guided a search of OVID Medline, CINAHL, OVID PsycINFO, OVID Embase, Cochrane Central, and Web of Science, plus backwards and forwards reference searching. We included interprofessional interventions, defined as any sys-tematic change (e.g., educational programs, symptom management, electronic medical record, etc.), for children dying from any cause. Studies were independently screened by two reviewers. Data were extracted by one team member and reviewed by a second. We extracted intervention elements, contextual factors, and implementation barri-ers/facilitators and generated frequencies from qualitative coding. Results: Of 11,643 screened articles; 44 met inclusion criteria. Most were in neonatal ICUs (28/44, 64%) and general PICUs (10/44, 23%). Most interventions aimed to improve cli-nician knowledge (25/44; 57%), augment clinical structures and processes (11/44; 25%), or enhance communication (N=8/44; 18%). Common delivery methods included clinical practice changes (N=25/44; 57%; e.g. protocols, order sets [N=12]) and educational sessions (N=20/44; 45%). Outcomes included clinician knowledge (N=17/44; 39%), qualitative feedback (N=18/44; 41%), feasibility/acceptability (N=12/44; 27%), or treatment utilization (N=11/44; 25%). Few examined families’ mental health (N=3; 7%) or bereavement (N=2; 5%). Few reported implementation facilitators or barriers. Conclusions: Most included studies targeted clinician outcomes through education. De-signing, testing, and implementing interventions focused on family outcomes is a critical next step.


  • Research Burden in Pediatric Cancer: A Mixed Methods Study From the PediQUEST Response Trial

    by Erika Tsuchiyose, Deborah Feifer, Alexandra F. Merz, Madeline Avery, Ijeoma J. Eche-Ugwu, Opeyemi Awofeso, Liliana Orellana, Denise Becker, Chris Feudtner, Jason L. Freedman, et al.


  • A Qualitative Descriptive Study to Assess Experiences and Care Needs of Patients With Cancer During the COVID-19 Pandemic

    by Ijeoma Julie Eche-Ugwu, Hayley Dunnack Yackel, Rachel A Pozzar, Marilyn J Hammer, Mary E Cooley

    The COVID-19 pandemic—one of the deadliest public health catastrophes in the contemporary era—resulted in the deaths of millions worldwide and severely affected global health infrastructures, with its residual impacts still felt in healthcare accessibility, mental wellness, and economic security (Lopez-Leon et al., 2021; Wiersinga et al., 2020). Often compared to the 1918–1919 influenza pandemic because of its rapid spread and massive death toll (Mackowiak, 2021), COVID-19 affected more than 446 million people globally (Sengar et al., 2022; Sinha & Kundu, 2021).

  • Illness Uncertainty in Parents of Children With Cancer—An Exploratory Analysis to Inform Intervention Development

    by Ijeoma Julie Eche‐Ugwu, Emanuele Mazzola, Sarah E. Stevens, Joanne Wolfe, Angela M. Feraco

    Background: Illness uncertainty—a state of struggling to make sense of illness‐related events—contributes to distress among parents of children with cancer. While some illness uncertainty is inescapable, uncertainty may be minimized through interventions targeting modifiable antecedents. Within the context of childhood cancer, parent and child characteristics associated with high illness uncertainty have not been identified. We sought to describe illness uncertainty among parents of children with cancer and explore potential associations with parent/child characteristics to identify populations that might benefit most from interventions to mitigate illness uncertainty. Procedure: We conducted an exploratory cross‐sectional analysis of parent‐reported survey data. We recruited parents of children with cancer cared for at a single academic pediatric cancer program in the northeastern United States who participated in two prospective studies ( n = 89 parents) between September 2016 and June 2018. Illness uncertainty was measured by the 31‐item Parent Perception of Uncertainty Scale (PPUS). Results: PPUS score distribution was slightly right‐skewed. Median PPUS score was 74, with an interquartile range of 67–83. Twenty‐four percent of parents strongly endorsed uncertainty regarding future planning, what their child can and cannot do, and their child's illness trajectory. Twenty percent strongly endorsed uncertainty from unanswered questions. Only 3% of parents reported their child's treatment regimen was too complex to understand. No significant associations were found between PPUS and parent/child characteristics. Conclusions: Future studies should examine additional parent and child characteristics to identify whether specific subgroups of parents may benefit most from interventions to reduce and manage illness uncertainty.


  • Depression and Anxiety as Moderators for a Behavioral Treatment for Dyspnea in Advanced Lung Cancer

    by Stephen B. Lo, Mia Holtze, Kathryn E. Post, Ijeoma Julie Eche-Ugwu, Mary E. Cooley, William F. Pirl, Jennifer S. Temel, Joseph A. Greer


  • A Systematic Literature Review of Interventions to Manage Hiccups in Patients With Cancer Undergoing Active Treatment

    by Rebecca T. Cure Student Sutcliffe, Ijeoma Julie PhD Eche-Ugwu

    Background: Patients with cancer often experience persistent or intractable hiccups, which negatively impact their quality of life. Yet, interventions aimed at managing hiccups among patients with cancer receiving active treatment are lacking. Objective: To describe existing evidence on interventions that address hiccup management in patients with cancer receiving active treatment with curative intent. Methods: Our narrative synthesis review was conducted through a systematic search of 3 electronic databases (CINAHL Complete, PubMed, and HOLLIS) augmented by hand search from January 2003 to July 2023 to retrieve peer-reviewed articles published in English. Our review was guided by PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) and registered through the National Institute for Health Research, International Prospective Register of Systematic Reviews (CRD42023444545). Results: The database searches yielded 2686 records. After removing duplicates and ineligible articles, 13 articles met the inclusion criteria. Most were noninterventional observational studies. The most common pharmacologic interventions were as follows: steroid rotation (replacing dexamethasone with methylprednisolone or omitting dexamethasone), baclofen, and olanzapine. Of these pharmacologic interventions, replacing dexamethasone with another antiemetic was most beneficial in reducing hiccups. Baclofen was also found to be beneficial in reducing chronic or intractable hiccups. Acupuncture was found to be an effective nonpharmacologic intervention. Conclusions: This review identified several promising interventions such as steroid rotation (replacing dexamethasone with methylprednisolone or omitting dexamethasone), baclofen, and acupuncture for hiccup management among patients with cancer undergoing active treatment. Implications for Practice: Future studies to identify efficacious interventions for hiccups among patients with cancer receiving active treatment are warranted.


  • Enabling Inclusive Psychosocial Research Strategies Among African American Parents of Children With Cancer

    by Ijeoma Julie Eche-Ugwu, Terese Aronowitz, Gloria E. White-Hammond, Alexandra Merz, Puja J. Umaretiya, Karen Bullock, Kimberly S. Johnson, Joanne Wolfe, Angela M. Feraco

  • Uncovering Structurally Differential Care: Pediatric Oncology Nurses’ Perspectives Caring for African American Families

    by Ijeoma Julie Eche-Ugwu, Teri Aronowitz, Elizabeth G. Broden, Alexandra Merz, Ariel Vernadakis, Karen Bullock, Joanne Wolfe, Angela M. Feraco